Northpointe Capital’s Zimmer Biomet ZBH Stock Holding History

Northpointe Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-17,611	Closed	-$2.18M	–	106
2019 Q1	$2.18M	Sell	17,611 -16,474	-48%	-$1.87M	0.69%	67
2018 Q4	$3.43M	Buy	+34,085	New	+$3.83M	0.77%	39
2017 Q1	–	Sell	-19,579	Closed	-$1.96M	–	199
2016 Q4	$1.96M	Sell	19,579 -552	-3%	-$59.2K	0.2%	156
2016 Q3	$2.54M	Buy	20,131 +856	+4%	+$106K	0.26%	140
2016 Q2	$2.25M	Sell	19,275 -14,478	-43%	-$1.64M	0.27%	130
2016 Q1	$3.49M	Buy	+33,753	New	+$3.27M	0.43%	85
2015 Q3	–	Sell	-35,021	Closed	-$3.71M	–	204
2015 Q2	$3.71M	Buy	+35,021	New	+$3.87M	0.44%	71

Other funds holding ZBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Northpointe Capital's ZBH Position: Q2 2019 in Review

Northpointe Capital sold out of Zimmer Biomet (ZBH) in Q2 2019, closing a stake of 17,611 shares — an estimated $2.18M sold.

Northpointe Capital first reported a position in ZBH in Q2 2015 and held it in 7 quarters. The position peaked at $3.71M in Q2 2015. 883 funds tracked by Wall St. Rank hold ZBH as of Q2 2019.

Northpointe Capital reported no remaining Zimmer Biomet position as of Q2 2019 after selling out during the quarter.
Northpointe Capital sold 17,611 Zimmer Biomet shares in Q2 2019, an estimated $2.18M.
Northpointe Capital first reported a position in Zimmer Biomet in Q2 2015 and held it in 7 quarters.
Northpointe Capital's Zimmer Biomet position peaked at $3.71M in Q2 2015.
883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2019.

Based on Northpointe Capital's 13F filing for Q2 2019, filed 26 Jul 2019.